Phreesia Dirección
Dirección controles de criterios 3/4
El CEO de Phreesia's es Chaim Indig , nombrado en Jan 2005, tiene una permanencia de 19.25 años. compensación anual total es $7.60M, compuesta por 6.8% salario y 93.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 2.3% de las acciones de la empresa, por valor de $26.57M. La antigüedad media del equipo directivo y de la junta directiva es de 3.3 años y 16.5 años, respectivamente.
Información clave
Chaim Indig
Chief Executive Officer (CEO)
US$7.6m
Compensación total
| Porcentaje del salario del CEO | 6.8% |
| Permanencia del CEO | 19.3yrs |
| Participación del CEO | 2.3% |
| Permanencia media de la dirección | 3.3yrs |
| Promedio de permanencia en la Junta Directiva | 16.5yrs |
Actualizaciones recientes de la dirección
Recent updates
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12
Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Phreesia Q3 2023 Earnings Preview
Dec 07Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M
Sep 07Phreesia: Their Time Has Passed
May 10Opportunistic Time To Buy Phreesia's Healthcare Disruption
Dec 27Are Phreesia, Inc. (NYSE:PHR) Investors Paying Above The Intrinsic Value?
Nov 08Is It Time To Consider Buying Phreesia, Inc. (NYSE:PHR)?
Sep 15Phreesia (PHR) Investor Presentation - Slideshow
Jun 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jan 31 2024 | n/a | n/a | -US$137m |
| Oct 31 2023 | n/a | n/a | -US$144m |
| Jul 31 2023 | n/a | n/a | -US$152m |
| Apr 30 2023 | n/a | n/a | -US$162m |
| Jan 31 2023 | US$8m | US$515k | -US$176m |
| Oct 31 2022 | n/a | n/a | -US$185m |
| Jul 31 2022 | n/a | n/a | -US$181m |
| Apr 30 2022 | n/a | n/a | -US$158m |
| Jan 31 2022 | US$9m | US$515k | -US$118m |
| Oct 31 2021 | n/a | n/a | -US$80m |
| Jul 31 2021 | n/a | n/a | -US$50m |
| Apr 30 2021 | n/a | n/a | -US$32m |
| Jan 31 2021 | US$6m | US$419k | -US$27m |
| Oct 31 2020 | n/a | n/a | -US$23m |
| Jul 31 2020 | n/a | n/a | -US$19m |
| Apr 30 2020 | n/a | n/a | -US$83m |
| Jan 31 2020 | US$10m | US$346k | -US$91m |
| Oct 31 2019 | n/a | n/a | -US$102m |
| Jul 31 2019 | n/a | n/a | -US$113m |
| Apr 30 2019 | n/a | n/a | -US$54m |
| Jan 31 2019 | US$510k | US$300k | -US$45m |
Compensación vs. Mercado: La compensación total de Chaim($USD7.60M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD3.44M).
Compensación vs. Ingresos: La compensación de Chaim ha sido consistente con los resultados de la empresa en el último año.
CEO
Chaim Indig (44 yo)
19.3yrs
Permanencia
US$7,604,450
Compensación
Mr. Chaim Indig co-founded Phreesia, Inc. in January 2005 and serves as Chief Executive Officer and Director since January 2005. Mr. Indig has helped to revolutionize the patient check-in experience. Under...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 19.3yrs | US$7.60m | 2.3% $ 26.8m | |
| Co-Founder & COO | 19.3yrs | US$3.95m | 1.34% $ 15.6m | |
| Senior Vice President of Life Sciences | 5.1yrs | US$3.92m | 0.37% $ 4.4m | |
| Chief Financial Officer | 1.1yrs | sin datos | 0.17% $ 2.0m | |
| VP, Principal Accounting Officer & Controller | less than a year | sin datos | 0.062% $ 725.9k | |
| Chief Technology Officer | less than a year | sin datos | sin datos | |
| General Counsel & Secretary | 3.7yrs | US$3.05m | 0.056% $ 656.5k | |
| Vice President of Corporate Communications | 3.3yrs | sin datos | sin datos | |
| Vice President of Marketing | no data | sin datos | sin datos | |
| Senior Vice President of Human Resources | 14yrs | sin datos | 0.21% $ 2.5m | |
| Chief Clinical Officer | 3yrs | sin datos | sin datos | |
| Chief Privacy Officer | less than a year | sin datos | sin datos |
3.3yrs
Permanencia media
49yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PHR se considera experimentado (3.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 19.3yrs | US$7.60m | 2.3% $ 26.8m | |
| Board Observer | no data | sin datos | sin datos | |
| Independent Director | 16.5yrs | US$228.70k | 0.063% $ 736.0k | |
| Independent Chairman | 19.3yrs | US$385.00k | 0.31% $ 3.6m | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 4.9yrs | US$252.45k | 0.018% $ 210.6k | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 5.5yrs | US$241.25k | 0.011% $ 126.0k |
16.5yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de PHR son experimentados ( 16.5 años antigüedad media).